AU Option Case Examples

Table showing Aztreonam use

Decreasing Aztreonam Use in a Veterans Affairs Hospital

Jesse Brown VA Medical Center has submitted data to the National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option since January 2013. In response to high aztreonam use, the facility developed training and educational materials to evaluate the risk of an adverse reaction from beta-lactam administration in a patient whose recorded medical history included a penicillin allergy. Read More.

Posted On: June 18, 2019

The figure shows the combined imipenem and meropenem rates for multiple facilities from 2013-2018. The outlier facility is shown in red and has a substantially higher rate than the comparetor facilities until after the intervention occurred. After the intervention, the outlier facility had a rate similar to other facilities in the healthcare system. Note: actual rates are withheld per the facility's request.

Using Telehealth to Decrease Carbapenem Use in a Critical Access Hospital

Using NHSN Antimicrobial Use (AU) Option data submitted from 2013-2018, Intermountain Healthcare system compared carbapenem use among its facilities and identified an outlier. After meeting with the local stewardship physician and pharmacist champions, an active prospective audit and feedback approach was initiated using telehealth. Read More.

Posted On: April 16, 2019

BSCA SAAR Values for Wards & ICU, 2016-2018

Targeting a Reduction in Fluoroquinolone Use within a Community Hospital

Submitting data into the NHSN Antimicrobial Use (AU Option) since 2016, Wilson Medical Center, a community hospital in North Carolina, used AU Option data to identify an area of high fluoroquinolone use. Once the area of high use and hospital locations were pinpointed, they developed an intervention to address the issue. Read More.

Posted On: January 30, 2019